+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Association of autoantibodies against the M2-muscarinic receptor with perinatal outcomes in women with severe preeclampsia

Association of autoantibodies against the M2-muscarinic receptor with perinatal outcomes in women with severe preeclampsia

Journal of Translational Medicine 11: 285

The goal of this study was to test the hypothesis that autoantibodies against M2-muscarinic acetylcholine receptor (M2-AAB) are associated with severe preeclampsia and increased risk of adverse perinatal outcomes. We conducted a case-control study comparing 60 women with severe preeclampsia to 60 women with normal pregnancy and 60 non-pregnant controls. A peptide, corresponding to amino acid sequences of the second extracellular loops of the M2 receptor, was synthesized as antigen to test for the presence of autoantibodies, using an enzyme-linked immunosorbent assay. The frequency and titer of M2-AAB were compared in the 3 groups. The risk of adverse perinatal outcomes among women with severe preeclampsia in the presence of M2-AAB was estimated. M2-AAB were positive in 31.7% (19/60) of patients with severe preeclampsia, in 10.0% (6/60) (p=0.006) of normal pregnant women and in 8.3% (5/60) (p=0.002) of non-pregnant controls. The presence of M2-AAB was associated with increased risk of adverse pregnancy complications (OR, 3.6; 95%CI, 1.0-12.6; p=0.048), fetal growth restriction (OR, 6.8; 95% CI, 2.0-23.0; p=0.002), fetal distress (OR, 6.7; 95% CI, 1.7-26.6; p=0.007), low Apgar score (OR, 5.3; 95% CI, 1.4-20.7; p=0.017), and perinatal death (OR, 4.3; 95% CI, 1.0-17.6; p=0.044) among women with severe preeclampsia. This study demonstrates, for the first time, an increase in M2-AAB in patients with severe preeclampsia. Women with severe preeclampsia who are M2-AAB positive are at increased risk for neonatal mortality and morbidity. We posit that M2-AAB may be involved in the pathogenesis of severe preeclampsia.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 051682117

Download citation: RISBibTeXText

PMID: 24206621

DOI: 10.1186/1479-5876-11-285

Related references

Maternal complications and perinatal outcomes associated with gestational hypertension and severe preeclampsia in Taiwanese women. Journal of the Formosan Medical Association 107(2): 129-138, 2008

Association of hypoproteinemia in preeclampsia with maternal and perinatal outcomes: A retrospective analysis of high-risk women. Journal of Research in Medical Sciences 21: 98, 2016

Association of autoantibodies against the M2-muscarinic receptor with long-term outcomes in peripartum cardiomyopathy patients: A 5-year prospective study. Journal of Cardiology 74(3): 251-257, 2019

Perinatal outcomes in women with preeclampsia and superimposed preeclampsia: do they differ?. American Journal of Obstetrics and Gynecology 204(6): 508.E1-7, 2011

The Association Between Trimester-Specific Weight Gain and Severe Preeclampsia/Adverse Perinatal Outcome in Gestational Diabetes Mellitus Complicated by Preeclampsia: A Retrospective Case Study. Diabetes Therapy 10(2): 725-734, 2019

Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies. Clinical Autonomic Research 4(5): 249-255, 1994

Study on different onset patterns and perinatal outcomes in severe preeclampsia. Zhonghua Fu Chan Ke Za Zhi 41(5): 302-306, 2006

Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gynecologic and Obstetric Investigation 59(2): 113-118, 2005

Association of previous severe low birth weight with adverse perinatal outcomes in a subsequent pregnancy among HIV-prevalent urban African women. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 136(2): 188-194, 2017

Predictors of adverse perinatal and maternal outcomes in severe preterm preeclampsia. 2007

Can thrombophilia worsen maternal and perinatal outcomes in cases of severe preeclampsia?. Pregnancy Hypertension 11: 81-86, 2018

Expression of autoantibody against the M2-muscarinic receptor in patients with severe preeclampsia. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 41(7): 707-710, 2016

Perinatal outcomes in preeclampsia complicated by severe proteinuria admitted at 32 weeks gestation. American Journal of Obstetrics & Gynecology 185(6 Suppl.): S172, 2001

Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome. Journal of the Turkish German Gynecological Association 12(2): 90-96, 2011

Recurrent preeclampsia and perinatal outcome: a study of women with recurrent preeclampsia compared with women with preeclampsia who remained normotensive during their prior pregnancies. Acta Obstetricia et Gynecologica Scandinavica 83(11): 1044-1048, 2004